BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/30/2021 8:56:50 AM | Browse: 600 | Download: 1937
 |
Received |
|
2020-09-20 15:01 |
|
Peer-Review Started |
|
2020-09-20 15:02 |
|
First Decision by Editorial Office Director |
|
2020-10-17 22:04 |
|
Return for Revision |
|
2020-10-21 15:11 |
|
Revised |
|
2020-12-30 11:58 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2021-01-25 07:48 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2021-01-26 03:29 |
|
Articles in Press |
|
2021-01-26 03:29 |
|
Edit the Manuscript by Language Editor |
|
2021-01-30 22:38 |
|
Typeset the Manuscript |
|
2021-03-16 10:40 |
|
Publish the Manuscript Online |
|
2021-03-30 08:56 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by Perbrolizumab: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiao-He Yu, Jian Huang, Nai-Jian Ge, Ye-Fa Yang and Jin-Yan Zhao |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
31971249 |
|
| Corresponding Author |
Jin-Yan Zhao, MD, Attending Doctor, Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, No. 85 Wujin Road, Shanghai 200080, China. jingy1213@163.com |
| Key Words |
Undifferentiated embryonal sarcoma of the liver; Perbrolizumab; Programmed cell death protein 1; Tumor mutation burden; Immunohistology; Case report |
| Core Tip |
Undifferentiated embryonal sarcoma of the liver is unusual neoplasms, which was mainly treated by resection and adjuvant multiagent chemotherapy. Immunotherapy, such as antibody of programmed cell death protein 1 (anti-PD-1) has not been reported to be used to treat this disease. Here we reported a recurrent UESL case in an adult which treated by Perbrolizumab and discuss the way to find the proper candidates for anti-PD-1 treatment. |
| Publish Date |
2021-03-30 08:56 |
| Citation |
Yu XH, Huang J, Ge NJ, Yang YF, Zhao JY. Recurrent undifferentiated embryonal sarcoma of the liver in adult patient treated by Perbrolizumab: A case report. World J Clin Cases 2021; 9(10): 2281-2288 |
| URL |
https://www.wjgnet.com/2307-8960/full/v9/i10/2281.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v9.i10.2281 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
